Contract Assay Development
& Bioconjugation Services

Fleet Bioprocessing will attend ELRIG Drug Discovery 2026 at ExCeL London, with a focus on ADC and bioconjugation development alongside pharma immunoassays supporting PK, PD, biomarker and ADA studies.

A research led CRO model gives clients the flexibility to access scientific input, specialist expertise and development support at the stage and level their project requires.

Rapid lateral flow tests for plant health can support earlier decisions across growing sites, storage facilities, processing plants and inspection points. This article explains how sampling, extraction, assay format, environmental performance, reader-based interpretation and manufacturing transfer affect the reliability of rapid agricultural testing.

Fleet Bioprocessing provides flexible, end-to-end contract lateral flow assay development, supporting projects from critical reagent screening and proof of concept through optimisation, performance verification and transfer to manufacture.

This article explains why reproducible conjugation methods are critical to antibody-drug conjugate development, supporting consistent efficacy, safety, regulatory compliance, and manufacturing efficiency.

Reader based multiplex lateral flow assays are opening new opportunities for biomarker signatures, structured data capture and algorithmic interpretation. This article explores how candidate markers can be assessed, translated into lateral flow and developed into reliable diagnostic systems with the reader, software, manufacture and regulatory pathway considered from the start.

This article compares sandwich vs competitive assays in ELISA and lateral flow, focusing on format selection, reagent strategy and assay development considerations.

Performance verification is the stage at which a lateral flow assay moves from development understanding to formal analytical evidence. This article explains how intended use and design inputs shape verification strategy, how CLSI-guided studies are structured, and why robust documentation is critical for transfer, submission, and product readiness.